Identification of differentially expressed genes at the single-cell level and prognosis prediction through bulk RNA sequencing data in breast cancer

H Chen, T Tian, H Luo, Y Jiang - Frontiers in Genetics, 2022 - frontiersin.org
Background: The invention and development of single-cell technologies have contributed a
lot to the understanding of tumor heterogeneity. The objective of this research was to …

MIF as a potential diagnostic and prognostic biomarker for triple‐negative breast cancer that correlates with the polarization of M2 macrophages

M Chen, H Liu, B Hong, Y Xiao, Y Qian - The FASEB Journal, 2024 - Wiley Online Library
Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine that plays a
crucial role in antitumor immunity. However, the role of MIF in influencing the tumor …

Integrative analysis for elucidating transcriptomics Landscapes of systemic lupus erythematosus

H Zhang, Y Wang, J Feng, S Wang, Y Wang… - Frontiers in …, 2021 - frontiersin.org
Systemic lupus erythematosus (SLE) is a complex and heterogeneous autoimmune disease
that the immune system attacks healthy cells and tissues. SLE is difficult to get a correct and …

单细胞测序技术在乳腺癌研究中的应用进展

刘强, 方仪, 王靖 - 中国癌症杂志, 2022 - china-oncology.com
乳腺癌是全球女性发病率最高的恶性肿瘤, 也是女性癌症相关致死的主要原因之一.
乳腺癌是一种高度异质性的疾病, 肿瘤间异质性和肿瘤内异质性使得精准分型治疗工作进展缓慢 …

WISP2 downregulation inhibits the osteogenic differentiation of BMSCs in congenital scoliosis by regulating Wnt/β-catenin pathway

Y Zheng, P Shen, M Tong, H Li, C Ren, F Wu… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Objectives Bone marrow mesenchymal stem cells (BMSCs) are instrumental in bone
development, metabolism, and marrow microenvironment homeostasis. Despite this, the …

Clinical trials with biologic primary endpoints in immuno-oncology: concepts and usage

J Isaacs, AC Tan, BA Hanks, X Wang, K Owzar… - Clinical Cancer …, 2022 - AACR
Clinical trials that have a pharmacokinetic or a pharmacodynamic immunologic mechanism
of action–based primary outcome could substantially improve the validity and efficiency of …

[PDF][PDF] Advances in single-cell sequencing technology and its applications in triple-negative breast cancer

M Li, T Yan, M Wang, Y Cai, Y Wei - Breast Cancer: Targets and …, 2022 - Taylor & Francis
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer and is
mainly treated with chemotherapy-based combination therapy. In recent years, with the …

Development and validation of a ligand–receptor pairs signature to predict outcome and provide a therapeutic strategy in gastric cancer

W Yang, X Zhao, L Duan, L Niu, Y Zhang… - Expert Review of …, 2023 - Taylor & Francis
Background An important factor in tumor development and progression is the tumor
microenvironment (TME), which is heterogeneous. Previous studies have mainly …

[HTML][HTML] Interaction between tumor microenvironment, autophagy, and epithelial-mesenchymal transition in tumor progression

WM Wang, H Shen, ZN Liu, YY Chen, LJ Hou… - Cancer Treatment and …, 2022 - Elsevier
Tumor microenvironment (TME) is the ecosystem surrounding a tumor to influence tumor
cells' growth, metastasis and immunological battlefield, in which the tumor systems fight …

In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients

W Kassuhn, PR Cutillas, M Kessler, J Sehouli… - Cancers, 2023 - mdpi.com
Simple Summary High-grade serous ovarian cancer (HGSOC) is a highly lethal form of
ovarian carcinoma characterized by molecular heterogeneity. This heterogeneity is a …